Structural and functional analysis of the complex between citrate and the zinc peptidase carboxypeptidase A

Enzyme Research

Volumn 2011, Issue 1, 2011, Pages

  Fernández, Daniel ^a   Boix, Ester ^a   Pallarès, Irantzu ^a   Avilés, Francesc X ^a   Vendrell, Josep ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLSUCCINIC ACID; CARBOXYPEPTIDASE A; CITRIC ACID; PHENYLALANINE; UNCLASSIFIED DRUG; ZINC ION; ZINC PEPTIDASE CARBOXYPEPTIDASE A;

ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ANALYSIS; ENZYME CONFORMATION; ENZYME KINETICS; ENZYME SPECIFICITY; ENZYME STRUCTURE; ENZYME SUBSTRATE COMPLEX; HYDROPHOBICITY; LIGAND BINDING; PRIORITY JOURNAL; PROTEIN FUNCTION; X RAY DIFFRACTION;

EID: 84855747311     PISSN: 20900406     EISSN: 20900414     Source Type: Journal    
DOI: 10.4061/2011/128676     Document Type: Article

References (49)

1. Vendrell J., Aviles F. X., Fricker L. D., Messerschmidt A., Bode W., Cygler M., Metallocarboxypeptidases. Handbook of Metalloproteins 2004 Chichester, UK John Wiley & Sons 176 189
2. Erickson R. H., Kim Y. S., Digestion and absorption of dietary protein. Annual Review of Medicine 1990 41 133 139 2-s2.0-0025319180 (Pubitemid 20121720)
3. Berger J., Olds Schneeman B., Stimulation of bile-pancreatic zinc, protein and carboxypeptidase secretion in response to various proteins in the rat. Journal of Nutrition 1986 116 2 265 272 2-s2.0-0022494955 (Pubitemid 16057969)
4. Berger J., Schneeman B. O., Intestinal zinc and carboxypeptidase A and B activity in response to consumption of test meals containing various proteins by rats. Journal of Nutrition 1988 118 6 723 728 2-s2.0-0023882010
5. Ibarz A., Garvín A., Garza S., Pagán J., Toxic effect of melanoidins from glucose-asparagine on trypsin activity. Food and Chemical Toxicology 2009 47 8 2071 2075 2-s2.0-68649122799 10.1016/j.fct.2009.05.025
6. Martin C. J., Evans W. J., Phytic acid-enhanced metal ion exchange reactions: the effect on carboxypeptidase A1. Journal of Inorganic Biochemistry 1989 35 4 267 288 2-s2.0-0024522421 10.1016/0162-0134(89)84017-6 (Pubitemid 19093870)
7. Parellada J., Suárez G., Guinea M., Inhibition of zinc metallopeptidases by flavonoids and related phenolic compounds: structure-activity relationships. Journal of Enzyme Inhibition 1998 13 5 347 359 2-s2.0-0031682313 (Pubitemid 28441953)
8. Martínez-Montemayor M. M., Hill G. M., Raney N. E., Rilington V. D., Tempelman R. J., Link J. E., Wilkinson C. P., Ramos A. M., Ernst C. W., Gene expression profiling in hepatic tissue of newly weaned pigs fed pharmacological zinc and phytase supplemented diets. BMC Genomics 2008 9, article 421 2-s2.0-53749101270 10.1186/1471-2164-9-421
9. Hilal M. A., Ung C. T., Westlake S., Johnson C. D., Carboxypeptidase-B activation peptide, a marker of pancreatic acinar injury, but not L-selectin, a marker of neutrophil activation, predicts severity of acute pancreatitis. Journal of Gastroenterology and Hepatology 2007 22 3 349 354 2-s2.0-33846904345 10.1111/j.1440-1746.2006.04550.x (Pubitemid 46238764)
10. Regnér S., Appelros S., Hjalmarsson C., Manjer J., Sadic J., Borgström A., Monocyte chemoattractant protein 1, active carboxypeptidase B and CAPAP at hospital admission are predictive markers for severe acute pancreatitis. Pancreatology 2008 8 1 42 49 2-s2.0-42549094868 10.1159/000114866 (Pubitemid 351587251)
11. Sáez J., Martínez J., Trigo C., Sánchez-Payá J., Compay L., Laveda R., Grió P., García C., Pérez-Mateo M., Clinical value of rapid urine trypsinogen-2 test strip, urinary trypsinogen activation peptide, and serum and urinary activation peptide of carboxypeptidase B in acute pancreatitis. World Journal of Gastroenterology 2005 11 46 7261 7265 2-s2.0-31344481714 (Pubitemid 43137673)
12. Matsugi S., Hamada T., Shioi N., Tanaka T., Kumada T., Satomura S., Serum carboxypeptidase A activity as a biomarker for early-stage pancreatic carcinoma. Clinica Chimica Acta 2007 378 1-2 147 153 2-s2.0-33846957741 10.1016/j.cca.2006.11.010 (Pubitemid 46242208)
13. Fialka F., Gruber R. M., Hitt R., Opitz L., Brunner E., Schliephake H., Kramer F. J., CPA6, FMO2, LGI1, SIAT1 and TNC are differentially expressed in early- and late-stage oral squamous cell carcinoma - a pilot study. Oral Oncology 2008 44 10 941 948 2-s2.0-51749119672 10.1016/j.oraloncology.2007.10. 011
14. Ross P. L., Cheng I., Liu X., Cicek M. S., Carroll P. R., Casey G., Witte J. S., Carboxypeptidase 4 gene variants and early-onset intermediate-to-high risk prostate cancer. BMC Cancer 2009 9, article 69 2-s2.0-63049106920 10.1186/1471-2407-9-69
15. Jeffrey K. D., Alejandro E. U., Luciani D. S., Kalynyak T. B., Hu X., Li H., Lin Y., Townsend R. R., Polonsky K. S., Johnson J. D., Carboxypeptidase E mediates palmitate-induced β -cell ER stress and apoptosis. Proceedings of the National Academy of Sciences of the United States of America 2008 105 24 8452 8457 2-s2.0-46149098906 10.1073/pnas.0711232105 (Pubitemid 351904777)
16. Johnson J. D., Proteomic identification of carboxypeptidase E connects lipid-induced β -cell apoptosis and dysfunction in type 2 diabetes. Cell Cycle 2009 8 1 38 42 2-s2.0-60749119458
17. Tregouet D. A., Schnabel R., Alessi M. C., Godefroy T., Declerck P. J., Nicaud V., Munzel T., Bickel C., Rupprecht H. J., Lubos E., Zeller T., Juhan-Vague I., Blankenberg S., Tiret L., Morange P. E., Activated thrombin activatable fibrinolysis inhibitor levels are associated with the risk of cardiovascular death in patients with coronary artery disease: the Athero Gene study. Journal of Thrombosis and Haemostasis 2009 7 1 49 57 2-s2.0-57749176449 10.1111/j.1538-7836.2008.03221.x
18. Leung L. L., Myles T., Nishimura T., Song J. J., Robinson W. H., Regulation of tissue inflammation by thrombin-activatable carboxypeptidase B (or TAFI). Molecular Immunology 2008 45 16 4080 4083 2-s2.0-55949084990 10.1016/j.molimm.2008.07.010
19. Schmuck C., How to improve guanidinium cations for oxoanion binding in aqueous solution?. The design of artificial peptide receptors. Coordination Chemistry Reviews 2006 250 23-24 3053 3067 2-s2.0-33750498924 10.1016/j.ccr.2006.04.001
20. Hayes D. M., Kollman P. A., Electrostatic potentials of proteins. 1. Carboxypeptidase A. Journal of the American Chemical Society 1976 98 11 3335 3345 2-s2.0-0017316036
21. Banci L., Bertini I., La Penna G., The enzymatic mechanism of carboxypeptidase: a molecular dynamics study. Proteins: Structure, Function and Genetics 1994 18 2 186 197 2-s2.0-0028158196 (Pubitemid 24055080)
22. Zhang K., Dong J., Auld D. S., A time-resolved X-Ray absorption fine structure study of substrate hydrolysis by carboxypeptidase A. Physica B (Amsterdam) 1995 208 & 209 1-4 719 721
23. Álvarez-Santos S., González-Lafont À., Lluch J. M., Oliva B., Avilés F. X., Theoretical study of the role of arginine 127 in the water-promoted mechanism of peptide cleavage by carboxypeptidase A. New Journal of Chemistry 1998 22 4 319 325 (Pubitemid 128704520)
24. Cho J. H., Kim D. H., Kim D. H., Lee K. J., Choi K. Y., The role of Tyr248 probed by mutant bovine carboxypeptidase A: insight into the catalytic mechanism of carboxypeptidase A. Biochemistry 2001 40 34 10197 10203 2-s2.0-0035964294 10.1021/bi010807j (Pubitemid 32800126)
25. Xu D., Guo H., Quantum mechanical/molecular mechanical and density functional theory studies of a prototypical zinc peptidase (carboxypeptidase A) suggest a general acid-general base mechanism. Journal of the American Chemical Society 2009 131 28 9780 9788 2-s2.0-67650504166 10.1021/ja9027988
26. Kim D. H., Chemistry-based design of inhibitors for carboxypeptidase A. Current Topics in Medicinal Chemistry 2004 4 12 1217 1226 2-s2.0-4444287344 10.2174/1568026043387908 (Pubitemid 39172333)
27. Adler M., Buckman B., Bryant J., Chang Z., Chu K., Emayan K., Hrvatin P., Islam I., Morser J., Sukovich D., West C., Yuan S., Whitlow M., Structures of potent selective peptide mimetics bound to carboxypeptidase B. Acta Crystallographica. Section D: Biological Crystallography 2008 64 2 149 157 2-s2.0-38549163713 10.1107/S0907444907057228 (Pubitemid 351161590)
28. Bunnage M. E., Owen D. R., TAFIa inhibitors in the treatment of thrombosis. Current Opinion in Drug Discovery and Development 2008 11 4 480 486 2-s2.0-46749103227 (Pubitemid 351950843)
29. Bravo-Osuna I., Vauthier C., Farabollini A., Millotti G., Ponchel G., Effect of chitosan and thiolated chitosan coating on the inhibition behaviour of PIBCA nanoparticles against intestinal metallopeptidases. Journal of Nanoparticle Research 2008 10 8 1293 1301 2-s2.0-48749093701 10.1007/s11051-008-9364-5
30. Rink R., Arkema-Meter A., Baudoin I., Post E., Kuipers A., Nelemans S. A., Akanbi H. H., Moll G. N., To protect peptide pharmaceuticals against peptidases. Journal of Pharmacological and Toxicological Methods 2010 61 2 210 218 2-s2.0-77950530516 10.1016/j.vascn.2010.02.010
31. Fernández D., Testero S., Vendrell J., Avilés F. X., francescxavier.aviles@uab.es Mobashery S., mobashery@nd.edu The X-ray structure of carboxypeptidase a inhibited by a thiirane mechanism-based ihibitor. Chemical Biology and Drug Design 2010 75 1 29 34 10.1111/j.1747-0285.2009.00907.x
32. Odell G. V., Ferry P. C., Vick L. M., Fenton A. W., Decker L. S., Cowell R. L., Ownby C. L., Gutierrez J. M., Citrate inhibition of snake venom proteases. Toxicon 1998 36 12 1801 1806 2-s2.0-0032400763 10.1016/S0041-0101(98) 00084-1 (Pubitemid 28532758)
33. Bonferoni M. C., Sandri G., Rossi S., Ferrari F., Gibin S., Caramella C., Chitosan citrate as multifunctional polymer for vaginal delivery. Evaluation of penetration enhancement and peptidase inhibition properties. European Journal of Pharmaceutical Sciences 2008 33 2 166 176 2-s2.0-38549137950 10.1016/j.ejps.2007.11.004
34. Collaborative Computational Project number 4, The CCP4 suite: programs for protein crystallography. Acta Crystallographica. Section D: Biological Crystallography 1994 50 760 776
35. Read R. J., Pushing the boundaries of molecular replacement with maximum likelihood. Acta Crystallographica. Section D Biological Crystallography 2001 57 10 1373 1382 2-s2.0-0035788107 10.1107/S0907444901012471 (Pubitemid 36117185)
36. Murshudov G. N., Vagin A. A., Dodson E. J., Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallographica. Section D: Biological Crystallography 1997 53 3 240 255 2-s2.0-0030924992 10.1107/S0907444996012255 (Pubitemid 27235885)
37. Davis I. W., Murray L. W., Richardson J. S., Richardson D. C., MolProbity: structure validation and all-atom contact analysis for nucleic acids and their complexes. Nucleic Acids Research 2004 32 W615 W619 2-s2.0-3242886389 10.1093/nar/gkh398 (Pubitemid 38997409)
38. Laskowski R. A., MacArthur M. W., Hutchinson E., Thornton J. M., PROCHECK: a program to check the stereochemical quality of protein structures. Journal of Applied Crystallography 1993 26 283 291
39. Emsley P., Cowtan K., Coot: model-building tools for molecular graphics. Acta Crystallographica. Section D: Biological Crystallography 2004 60 12 2126 2132 2-s2.0-13244281317 10.1107/S0907444904019158 (Pubitemid 41742764)
40. Cheng Y., Prusoff W. H., Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochemical Pharmacology 1973 22 23 3099 3108 2-s2.0-0015861774 10.1016/0006-2952(73)90196-2
41. Fernández D., Boix E., ester.boix@uab.cat Pallarès I., Avilés F. X., Vendrell J., josep.vendrell@uab.cat Analysis of a new crystal form of procarboxypeptidase B: further insights into the catalytic mechanism. Biopolymers 2010 93 2 178 185 10.1002/bip.21320
42. Firth-Clark S., Kirton S. B., Willems H. M. G., Williams A., De novo ligand design to partially flexible active sites: application of the ReFlex algorithm to carboxypeptidase A, acetylcholinesterase, and the estrogen receptor. Journal of Chemical Information and Modeling 2008 48 2 296 305 2-s2.0-41649095370 10.1021/ci700282u (Pubitemid 351479118)
43. Byers L. D., Wolfenden R., A potent reversible inhibitor of carboxypeptidase A. The Journal of Biological Chemistry 1972 247 2 606 608 2-s2.0-0015522392
44. Galardy R. E., Kortylewicz Z. P., Inhibition of carboxypeptidase A by aldehyde and ketone substrate analogues. Biochemistry 1984 23 9 2083 2087 2-s2.0-0021769859
45. Bonferoni M. C., Sandri G., Rossi S., Ferrari F., Caramella C., Chitosan and its salts for mucosal and transmucosal delivery. Expert Opinion on Drug Delivery 2009 6 9 923 939 2-s2.0-70249139516 10.1517/17425240903114142
46. Kean T., Roth S., Thanou M., Trimethylated chitosans as non-viral gene delivery vectors: cytotoxicity and transfection efficiency. Journal of Controlled Release 2005 103 3 643 653 2-s2.0-16344377289 10.1016/j.jconrel.2005. 01.001 (Pubitemid 40471022)
47. Ursino M. G., Poluzzi E., Caramella C., De Ponti F., fabrizio. deponti@unibo.it Excipients in medicinal products used in gastroenterology as a possible cause of side effects. Regulatory Toxicology and Pharmacology 2011 60 1 93 105 10.1016/j.yrtph.2011.02.010
48. Del Curto M. D., Maroni A., Palugan L., Zema L., Gazzaniga A., andrea.gazzaniga@unimi.it Sangalli M. E., Oral delivery system for two-pulse colonic release of protein drugs and protease inhibitor/absorption enhancer compounds. Journal of Pharmaceutical Sciences 2011 100 8 3251 3259 10.1002/jps.22560
49. Wentland M. P., Raza S., Gao Y., 96-Well plate colorimetric assay for Ki determination of (±)-2-Benzylsuccinic acid, an inhibitor of carboxypeptidase A. A laboratory experiment in drug discovery. Journal of Chemical Education 2004 81 3 398 400 2-s2.0-1542375756